Transfusion-Acquired HIV: History, Evolution of Screening Tests, and Current Challenges of Unreported Antiretroviral Drug Use in Brazil

• Published in: Viruses Vol. 14; no. 10; p. 2214
• Main Authors: Nishiya, Anna S, Ferreira, Suzete C, Salles, Nanci A, Rocha, Vanderson, Mendrone-Júnior, Alfredo
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.10.2022; MDPI
• Subjects: Acquired immune deficiency syndrome; AIDS; Antiretroviral agents; Antiviral agents; Blood donors; Blood transfusion; Blood transfusions; Diagnosis; Disease transmission; Dosage and administration; Health aspects; History; HIV; HIV infection; HIV prophylaxis; Human immunodeficiency virus; Medical research; Medicine, Experimental; Motivation; Opinion; Prophylaxis; Sexually transmitted diseases; Statistics; STD; transfusion risk; transfusion-transmission; window period; Brazil; United States > US
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v14102214

Prevention of HIV acquisition by blood transfusion from its emergence to the present day is reviewed, and current challenges are delineated. The experience of Fundação Pró-Sangue/Hemocentro de São Paulo, Brazil, is highlighted in the quest for improvements in blood safety and the evolution of increasingly sensitive and specific screening tests. Concerns and establishing stringent criteria in the screening of potential blood donors are emphasized, and the current criteria for identifying and deferring candidates at high risk of acquiring sexually transmitted diseases are summarized. Future challenges relate to the identification of donors with unreported use of antiretroviral drugs for prophylaxis against possible HIV exposure or for treatment of an HIV infection whose viral expression is undetectable by current analyses. There is a need to better understand the motivation of HIV-exposed donors and to educate them about the risk of transfusion-mediated HIV transmission despite having low or undetectable viral loads. In situations in which traditional HIV RNA or antibody detection assays remain negative, more sensitive analyses are needed to identify potential donors at risk for HIV transmission.